Bend Research, PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) have developed a new technology for thermostable vaccine production. The technology uses novel formulation and spray-drying processing methods, allowing the partners to develop a spray-dried flu vaccine product that is stable at 50°C for more than two months. The technology can also be applied to emerging flu and other vaccines.     The next phase of development for the partnership includes developing a commercial...